Jane Street

Jane Street’s Connect Biopharma Holdings CNTB Stock Holding History

Jane Street’s Portfolio CNTB Stock Details CNTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,400	Closed	-$32.5K	–	11728
2026 Q1	$32.5K	Buy	+12,400	New	+$32.3K	﹤0.01%	11096

Other funds holding CNTB

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

Richmond Brothers Jackson, Michigan $192M AUM 23.02% 1-Year Est. Return

David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return

Jane Street's CNTB Position: Q2 2026 in Review

Jane Street sold out of Connect Biopharma Holdings (CNTB) in Q2 2026, closing a stake of 39,598 shares — an estimated $104K sold.

Jane Street first reported a position in CNTB in Q4 2025 and held it in 2 quarters. The position peaked at $232K in Q4 2025. 56 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

Jane Street reported no remaining Connect Biopharma Holdings position as of Q2 2026 after selling out during the quarter.
Jane Street sold 39,598 Connect Biopharma Holdings shares in Q2 2026, an estimated $104K.
Jane Street first reported a position in Connect Biopharma Holdings in Q4 2025 and held it in 2 quarters.
Jane Street's Connect Biopharma Holdings position peaked at $232K in Q4 2025.
56 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.